NASDAQ:PLXSPlexus Stock Price, Forecast & News

Plexus' stock was trading at $60.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PLXS stock has increased by 10.1% and is now trading at $66.83. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Plexus.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, July 15th 2020. View our earnings forecast for Plexus.

Plexus Corp. (NASDAQ:PLXS) posted its quarterly earnings results on Wednesday, April, 22nd. The technology company reported $0.61 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.56 by $0.05. The technology company had revenue of $767 million for the quarter, compared to the consensus estimate of $741.22 million. Plexus had a return on equity of 11.45% and a net margin of 3.27%. Plexus's revenue was down 2.8% compared to the same quarter last year. During the same period last year, the firm posted $0.79 earnings per share. View Plexus' earnings history.

Plexus updated its third quarter earnings guidance on Wednesday, April, 22nd. The company provided EPS guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus estimate of $0.67. The company issued revenue guidance of $790-830 million, compared to the consensus revenue estimate of $763.23 million.

5 analysts have issued 12-month price objectives for Plexus' stock. Their forecasts range from $67.00 to $83.00. On average, they expect Plexus' share price to reach $73.00 in the next year. This suggests a possible upside of 9.2% from the stock's current price. View analysts' price targets for Plexus.

Press coverage about PLXS stock has trended very negative on Thursday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Plexus earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutPlexus.

Plexus saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,230,000 shares, an increase of 8.8% from the April 30th total of 1,130,000 shares. Based on an average daily trading volume, of 191,200 shares, the short-interest ratio is currently 6.4 days. Currently, 4.3% of the company's shares are sold short. View Plexus' Current Options Chain.

Some companies that are related to Plexus include Trimble (TRMB), IPG Photonics (IPGP), Mercury Systems (MRCY), Jabil (JBL), Fabrinet (FN), Sanmina (SANM), KEMET (KEM), TTM Technologies (TTMI), Methode Electronics (MEI), Benchmark Electronics (BHE), CTS (CTS), Park Electrochemical (PKE), Key Tronic (KTCC) and Neonode (NEON). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), QUALCOMM (QCOM), Twitter (TWTR) and ConocoPhillips (COP).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.58%), Disciplined Growth Investors Inc. MN (9.70%), Franklin Resources Inc. (4.11%), State Street Corp (3.15%), Victory Capital Management Inc. (2.89%) and Victory Capital Management Inc. (2.89%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View institutional ownership trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including Silvercrest Asset Management Group LLC, Franklin Resources Inc., BlackRock Inc., Morgan Stanley, Morgan Stanley, Fisher Asset Management LLC, Disciplined Growth Investors Inc. MN, and Chartwell Investment Partners LLC. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey, and Yong Jin Lim. View insider buying and selling activity for Plexus.

PLXS stock was purchased by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Victory Capital Management Inc., Victory Capital Management Inc., Channing Capital Management LLC, Massachusetts Financial Services Co. MA, Grantham Mayo Van Otterloo & Co. LLC, New York State Common Retirement Fund, and State Street Corp. View insider buying and selling activity for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $66.83.

Plexus has a market capitalization of $1.95 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.

The official website for Plexus is www.plexus.com.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]